The role of a soluble TNFalpha receptor fusion protein (etanercept) in corticosteroid refractory asthma: a double blind, randomised, placebo controlled trial.
Morjaria, J B
The role of a soluble TNFalpha receptor fusion protein (etanercept) in corticosteroid refractory asthma: a double blind, randomised, placebo controlled trial. [electronic resource] - Thorax Jul 2008 - 584-91 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1468-3296
10.1136/thx.2007.086314 doi
Adult
Anti-Asthmatic Agents--therapeutic use
Anti-Inflammatory Agents, Non-Steroidal--therapeutic use
Asthma--drug therapy
Biomarkers--blood
Bronchial Hyperreactivity--physiopathology
Double-Blind Method
Drug Resistance
Etanercept
Female
Forced Expiratory Volume--drug effects
Humans
Immunoglobulin G--therapeutic use
Male
Middle Aged
Quality of Life
Receptors, Tumor Necrosis Factor--therapeutic use
Sputum--chemistry
Surveys and Questionnaires
Treatment Outcome
Vital Capacity--drug effects
The role of a soluble TNFalpha receptor fusion protein (etanercept) in corticosteroid refractory asthma: a double blind, randomised, placebo controlled trial. [electronic resource] - Thorax Jul 2008 - 584-91 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1468-3296
10.1136/thx.2007.086314 doi
Adult
Anti-Asthmatic Agents--therapeutic use
Anti-Inflammatory Agents, Non-Steroidal--therapeutic use
Asthma--drug therapy
Biomarkers--blood
Bronchial Hyperreactivity--physiopathology
Double-Blind Method
Drug Resistance
Etanercept
Female
Forced Expiratory Volume--drug effects
Humans
Immunoglobulin G--therapeutic use
Male
Middle Aged
Quality of Life
Receptors, Tumor Necrosis Factor--therapeutic use
Sputum--chemistry
Surveys and Questionnaires
Treatment Outcome
Vital Capacity--drug effects